Miedema et al. labeled an anti-LAG-3 antibody with 89Zr and investigated the potential use of [89Zr]Zr-BI 754111 in a limited number of patients with head and neck cancer (n = 2) and with lung cancer (n = 4). The gene discussed is LAG3; the disease is lung carcinoma.